ID: ALA1091036

Max Phase: Preclinical

Molecular Formula: C35H48N4O4

Molecular Weight: 588.79

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(C2(CNC(=O)Nc3c(C(C)C)cc(N)cc3C(C)C)CCN(c3ccccc3OCCCO)CC2)c1

Standard InChI:  InChI=1S/C35H48N4O4/c1-24(2)29-21-27(36)22-30(25(3)4)33(29)38-34(41)37-23-35(26-10-8-11-28(20-26)42-5)14-16-39(17-15-35)31-12-6-7-13-32(31)43-19-9-18-40/h6-8,10-13,20-22,24-25,40H,9,14-19,23,36H2,1-5H3,(H2,37,38,41)

Standard InChI Key:  HORIEIZZCKPONB-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acyl coenzyme A:cholesterol acyltransferase 1 2344 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 588.79Molecular Weight (Monoisotopic): 588.3676AlogP: 6.65#Rotatable Bonds: 12
Polar Surface Area: 109.08Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.54CX LogP: 5.71CX LogD: 5.71
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.14Np Likeness Score: -0.74

References

1. Asano S, Ban H, Tsuboya N, Uno S, Kino K, Ioriya K, Kitano M, Ueno Y..  (2010)  A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia.,  53  (8): [PMID:20356098] [10.1021/jm901909p]

Source